In a major setback for Purdue Pharma, Endo Pharmaceutical Holdings Inc. has won an appeals court ruling allowing it to sell a generic version of the painkiller OxyContin.
In a decision with broad implications for the pharmaceutical industry, a U.S. appeals court has ruled that brand-name drug companies have the right to sell unbranded versions of their own drugs even if they undercut sales of generic competitors.
An appeals court has rejected a motion for a rehearing of a ruling in favor of General Cigar over trademark rights to Cuba’s famous Cohiba cigars in the U.S.
The U.S. Court of Appeals for the Federal Circuit has affirmed a lower court’s decision favoring portable storage maker SmartDisk in a patent lawsuit filed by a smaller rival.
Stephen Slesinger Inc. has asked a California appeals to reinstate the company’s 14-year-old suit against Walt Disney Co. over copyrights and merchandising rights to Winnie the Pooh.
A U.S. appeals court has rejected a constitutional challenge to a trade treaty that returned foreign works that had fallen into the public domain back to protected status.
A Canadian appeals court has upheld a lower court’s ruling barring the release of the identities of suspected music pirates, but offered the recording industry a blueprint for how to proceed in future lawsuits.
The U.S. Court of Appeals for the Federal Circuit has granted Canadian generics maker Apotex Inc. a second chance to seek the invalidation of a patent for Allergan Inc.’s eye-inflammation treatment Acular.
A jury in Jefferson County Circuit Court has ruled that an Arizona software company stole an Alabama rival’s trade secrets and ordered the Arizona company to pay the Alabama company $19.5 million in damages.
The U.S. Court of Appeals for the Federal Circuit has granted eBay’s petition to stay a closely watched patent lawsuit brought by MercExchange, stopping the case from going back to the district court until the Supreme Court rules on eBay's request to hear the case.
The U.S. Court of Appeals for the Federal Circuit has affirmed in part a jury verdict in medical device maker ArthroCare Corp.’s patent infringement lawsuit against rival Smith & Nephew, but revived Smith & Nephew’s countersuit based on antitrust claims against ArthroCare and Ethicon.
In a surprising decision, a federal appeals court has overturned Federal Communications Commission rules requiring antipiracy technology in digital television sets.
In a case with broad implications for interpretations of the Digital Millennium Copyright Act, the U.S. Supreme Court has refused to hear an appeal from the Chamberlain Group in its patent dispute with Skylink Technologies Inc. over aftermarket products.
In a victory for the Gillette Co., the U.S. Court of Appeals for the Federal Circuit has sent the company’s patent infringement lawsuit against Energizer Holdings, Inc. back to Massachusetts federal court.
Circuit City will rename its RadioShack stores in Canada The Source after losing a U.S. trademark lawsuit brought by rival RadioShack Corp.
In a case with wide implications for settlements of patent disputes in the pharmaceutical industry, the U.S. Federal Trade Commission has asked the U.S. Court of Appeals for the 11th Circuit in Atlanta to reconsider a ruling by a three-judge panel last month that dismissed the agency’s complaints against Schering-Plough Corp.
The U.S. Court of Appeals for the Federal Circuit has denied Merck’s petition for an en-banc rehearing of a panel’s decision that invalidated one of the patents for its best-selling osteoporosis treatment Fosamax.
The U.S. Court of Appeals for the Federal Circuit has overturned a California federal court’s decision to invalidate a satellite-control technology patent belonging to Loral Space & Communications Ltd. in a patent suit against Lockheed Martin Corp.
In a case with broad implications for the pharmaceutical industry, the U.S. Supreme Court appeared skeptical Wednesday of an appeal court’s narrow interpretation of a statute that shields drug companies from patent liability in their research and development.
Generic drug makers Dr. Reddy's Laboratories and Ivax have vowed to appeal last week's ruling by an Indiana federal court that upheld Eli Lilly's patent on the blockbuster schizophrenia drug Zyprexa.